Bioxytran (BIXT) FCF Margin Growth (5y) (2015 - 2018)
Bioxytran (BIXT) FCF Margin Growth (5y) (2015 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1,696.00 |
| Mar 31, 2018 | -595.00 |
| Dec 31, 2017 | 960.00 |
| Sep 30, 2017 | 63,603.00 |
| Jun 30, 2017 | -912.00 |
| Mar 31, 2017 | -9,840.00 |
| Dec 31, 2016 | 80,741.00 |
| Sep 30, 2016 | 58,603.00 |
| Jun 30, 2016 | 30,925.00 |
| Mar 31, 2016 | 26,127.00 |
| Dec 31, 2015 | 25,049.00 |
| Sep 30, 2015 | 253,705.00 |